This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.
Dayan Goodenowe’s research focuses on using biomarkers like plasmalogens for early cancer detection.”
